Davita Inc. Stock
Davita Inc. Stock
Davita Inc. gained 1.020% today.
Our community identified positive and negative aspects for Davita Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Davita Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Davita Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Davita Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Davita Inc. | 1.020% | 2.529% | -2.037% | -29.660% | -29.396% | 46.459% | 15.660% |
| Ensign Group Inc. | -1.340% | -2.614% | -4.487% | 10.370% | 17.323% | - | - |
| Amn Healthcare Svs | 2.220% | -1.429% | -4.828% | -45.669% | -39.474% | -87.103% | -75.357% |
| Chemed Corp. | 1.120% | 0.556% | -5.729% | -30.385% | -27.309% | - | - |
Comments
DaVita (NYSE:DVA) had its price target lowered by analysts at Bank of America Corporation from $145.00 to $140.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at UBS Group AG from $169.00 to $175.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at Bank of America Co. from $139.00 to $145.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat